Chemours projects $825M-$975M adjusted EBITDA for 2025 with focus on cost savings
Opteon growth, cost-saving victories, and 2025 forecasts. Learn about key trends shaping the company's future.
The Victoria Advocate13d
Post Holdings Reports Results for the First Quarter of Fiscal Year 2025; Raises Fiscal Year 2025 Outlook
Adjusted EBITDA and segment Adjusted EBITDA reflect adjustments for income tax expense/benefit, interest expense, net and depreciation and amortization, and the following adjustments discussed ...